The Expert Opinion series of journals provide systematic and authoritative analysis to support every stage in the pharmaceutical pipeline. With 11 internationally peer-reviewed journals, we cover the full spectrum of drug development and application.
11 phase-specific journals
Our expertly crafted review articles enable the pharmaceutical R&D community to access and track the key advances that lead to the creation of new drugs.
What makes us really stand out?
Unusually for research publishing, each paper published in Expert Opinion concludes not with the ?Conclusion? but with an ?Expert Opinion?.ÿ This is where our authors, all internationally recognised experts in their field and key opinion leaders within the industry, give their own personal view. They put their knowledge, expertise and experience to the test, stating where the research is now, where it should go next, and how it should get there.
And, because we recognise that there are two sides to every argument, reader feedback is always welcome.
